Author: jeansforgenesau

Prof. Ian Alexander was invited to speak at the SSIEM (Society for the Study of Inborn Errors of Metabolism) Conference held in Geneva, Switzerland (30 August 2011 – 2 September 2011). Prof Alexander presented an overview of gene therapy for metabolic disorders especially ornithine-transcarbamylase deficiency.

When

30/Aug/2011 04:23 PM

Where

Details

The aim of the society is to foster study of inherited metabolic disorders and related topics. The society was founded in 1963 and aims to promote exchange of ideas between professional workers in different disciplines who are interested in inherited metabolic disease.

Our Quality Manager, Richard Makin, attended the Phacilitate Cell and Gene Therapy Forum in Singapore on 19-21 September 2011. The forum focused on the commercial opportunities and challenges (regulatory and political) in the emerging Asian and Australia markets.   A number of novel research and commercial products were showcased including preventive and regenerative therapies. Key stakeholders also discussed partnering opportunities with commercial and academic, hospital-based projects and strategic measures in capitalising on this evolving industry.

1/10/2011 In addition to working hard to maintain NATA and FACT accreditation a number of key SCGT staff have donated their time in 2012 to provide technical expertise to the accreditation bodies in assessments of other cellular therapy facilities. For a number of years our staff have assisted as NATA technical assessors. In 2012, we have provided inspectors for the clinical, collection and laboratory components of FACT inspections.

Dr Ken Micklethwaite, Dr Leighton Clancy and Vicki Antonenas presented some of their findings at the joint scientific meeting at the Sydney Convention and Exhibition Centre Darling Harbour 30 October -2 November 2011. They presented data on our Immunotherapy research and BMT clinical service.

When

30/Oct/2011 04:23 PM

Where

Prof Chapman recently chaired the Transmission of Malignancy committee of the Notify Project. The Notify Project, an initiative of the World Health and assisted reproduction. This database is readily available via www.notifylibrary.org and is a valuable resource for institutions worldwide requiring the latest as well as historical vigilance and surveillance information.  

The Children’s Hospital at Westmead Blood and Marrow Transplant Service has earned FACT accreditation for pediatric autologous and allogeneic hematopoietic progenitor cell transplantation, bone marrow and peripheral blood cellular therapy product collection, and cellular therapy product processing. They achieved accreditation by demonstrating compliance with the FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing and Administration.

The SCGT Quality Manager, Richard Makin, presented on the challenges of implementing a quality system in the context of the Biological’s Framework.

When

01/Jun/2012 04:20 PM

Where

SCGT achieved outstanding success with the recent awarding of five NHMRC Project grants, to commence in 2012. The National Health and Medical Research Council (NHMRC) is Australia’s leading expert body promoting the development and maintenance of public and individual health standards.